Group 1 - The DRG/DIP concept rose by 2.42% on August 13, with a net inflow of 456 million yuan from main funds, indicating positive market sentiment [1] - A total of 13 stocks within the concept increased in value, while 6 stocks experienced declines [1] - The top net inflows were recorded for Rongke Technology (422 million yuan), Saily Medical (109 million yuan), and Digital Certification (75.44 million yuan) [1] Group 2 - Rongke Technology's latest price was 22.92 yuan, with a change of 0.04% and a net inflow of 422 million yuan, representing 24.34% of the main fund's net inflow [1] - Saily Medical saw a price of 31.09 yuan, with a significant increase of 6.55% and a net inflow of 109 million yuan, accounting for 6.54% of the total [1] - Digital Certification's price was 37.75 yuan, with a rise of 9.26% and a net inflow of 75.44 million yuan, making up 5.98% of the total [1]

资金流向方面，今日主力资金净流入1.09亿元，占比成交额6.54%。其中，超大单净流入8233.52万元、 占成交额4.93%，大单净流入2691.33万元、占成交额1.61%，中单净流出流出8469.74万元、占成交额 5.07%，小单净流出2455.11万元、占成交额1.47%。 塞力医疗最新一期业绩显示，截至2025一季报，公司营业总收入2.87亿元、同比减少40.75%，归属净利 润1432.09万元，同比减少553.66%，扣非净利润2846.33万元，同比减少3228.81%，流动比率1.931、速 动比率1.591、资产负债率58.57%。 金融界消息 截至2025年8月13日收盘，塞力医疗（603716）报收于31.09元，上涨6.55%，换手率 29.12%，成交量55.62万手，成交金额16.71亿元。 通过天眼查大数据分析，塞力斯医疗科技集团股份有限公司共对外投资了70家企业，参与招投标项目 146次，知识产权方面有商标信息9条，专利信息7条，此外企业还拥有行政许可26个。 来源：金融界 天眼查商业履历信息显示，塞力斯医疗科技集团股份有限公司，成立于2004年，位于武汉市，是一家以 从事 ...

券商科创债今年来发行规模超过400亿元。头部券商专项支持科技创新领域的力度不断加大。申万宏源、中原证券等券商相继获批债券发行额度。7月A股新 开户196.36万户，同比增长70.5%，环比增长19.27%。截至7月末，今年以来A股累计新开1456.13万户。新增开户数据反映出市场活跃度的提升，为券商业务 发展提供支撑。 创新药概念股再度活跃获政策支持 8月13日，A股市场呈现震荡上行态势。创业板指数表现突出，半日涨幅达到2.81%。沪指突破2024年10月8日高点，创下2021年12月17日以来新高。沪深两 市半日成交额达1.32万亿元，较上个交易日放量1181亿元。券商股盘中出现异动拉升，创新药概念股同步走强，为市场注入新的活力。 券商板块异动拉升显现资金青睐 券商股在盘中表现活跃，国盛金控连续两个交易日涨停。证券板块主力资金净流入28.45亿元，位居各行业板块资金流入榜首位。东方财富全天成交额达 110.44亿元，居全市场第一位。金融科技方向上，中科金财、同花顺、大智慧等个股领涨。 市场上涨期间，券商板块受到资金追捧。背后体现的是"卖斧子"的投资逻辑。过去券商主要依靠佣金收入，现在这把"斧子"的载体正转向 ...

Group 1 - The core viewpoint of the news is that the brain-computer interface concept stocks in the A-share market have shown strong performance, with several companies experiencing significant price increases [1] Group 2 - Company performance highlights include: - Innovation Medical (002173) saw a price increase of 10.00%, with a total market capitalization of 9.995 billion and a year-to-date increase of 184.55% [2] - Pulite (002324) increased by 7.51%, with a market cap of 15.9 billion and a year-to-date increase of 50.88% [2] - Chengyitong (300430) rose by 6.65%, with a market cap of 6.657 billion and a year-to-date increase of 59.67% [2] - Saily Medical (603716) increased by 5.45%, with a market cap of 5.878 billion and a year-to-date increase of 326.18% [2] - Sanbo Brain Science (301293) rose by 3.79%, with a market cap of 12.9 billion and a year-to-date increase of 44.76% [2] - The MACD golden cross signal formation indicates a positive trend for these stocks [1]

证券代码：603716 证券简称：塞力医疗 公告编号：2025-070 债券代码：113601 债券简称：塞力转债 塞力斯医疗科技集团股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ? 塞力斯医疗科技集团股份有限公司（以下简称"公司"）控股股东赛海 （上海）健康科技有限公司（以下简称"赛海科技"）持有公司 21,642,540 股 无限售条件流通股股票，占公司总股本的 11.33%（截至 2025 年 6 月 30 日总股 本，下同）。赛海科技累计质押公司股份 14,000,000 股，占其持有公司股份比 例为 64.69%，占公司总股本比例为 7.33%。 ? 公司实际控制人温伟先生持有公司股份 9,634,208 股，占公司总股本比 例为 5.04%。近日，温伟先生将其中 3,000,000 股股份办理完成了解除质押登记 手续，本次解除质押手续办理完毕后，温伟先生累计质押公司股份 5,300,000 股，占其持有公司股份比例为 55.01%，占公司总股本比例为 2.77%。 股东名称 温伟 本 ...

Core Points - The company will pay interest on its convertible bonds on August 21, 2025, for the period from August 21, 2024, to August 20, 2025 [1][2] - The total amount of the convertible bonds issued is 543.31 million yuan, with a face value of 100 yuan per bond [1][4] - The coupon rate for the fifth year is set at 2.50%, resulting in an interest payment of 2.50 yuan per bond (before tax) [2][4] Summary by Sections Bond Information - The convertible bonds are named "塞力转债" with a code of 113601, and they can be converted into A-shares of the company [1][4] - The bonds were issued on August 21, 2020, and will mature on August 20, 2026 [1][4] - The bond's initial conversion price was 16.98 yuan per share, while the latest conversion price is 12.00 yuan per share [4] Interest Payment Details - Interest will be paid annually, with the first payment occurring on August 21, 2021 [2][5] - The interest payment dates are as follows: - Record date: August 20, 2025 - Ex-dividend date: August 21, 2025 - Payment date: August 21, 2025 [2][4] Taxation Information - Individual investors are subject to a 20% tax on interest income, resulting in a net payment of 2.00 yuan per bond after tax [6][7] - Non-resident enterprises are exempt from corporate income tax on interest income until December 31, 2025 [7] Contact Information - The company is located at 1310 Jinshan Avenue, Dongxihu District, Wuhan, and can be contacted via email at ir@thalys.net.cn [7][8]

Core Viewpoint - As of August 12, 2025, the stock price of Sely Medical closed at 29.18 yuan, reflecting a decline of 3.89% from the previous trading day, with a trading volume of 1.346 billion yuan and a turnover rate of 23.82% [1] Company Overview - Sely Medical's main business encompasses both the medical commercial and industrial sectors, with the commercial segment accounting for over 97% of its revenue [1] - The company is associated with several concept sectors, including pharmaceutical commerce, Hubei region, and biological vaccines [1] Shareholder Activity - On the evening of August 12, the company announced that its actual controller, Wen Wei, has fully released the pledge on 3 million shares. Following this release, the total pledged shares held by Wen Wei decreased to 5.3 million, representing 55.01% of his total holdings [1] Capital Flow - On August 12, Sely Medical experienced a net outflow of 206 million yuan in principal funds, which accounted for 3.7% of its circulating market value. Over the past five trading days, the cumulative net outflow reached 131 million yuan, representing 2.34% of its circulating market value [1]

（编辑 姚尧） 证券日报网讯 8月12日晚间，塞力医疗发布公告称，公司于近日收到实际控制人温伟先生的通知，温伟 先生将前期质押给北京湘钢钢铁材料销售有限公司的3，000，000股股份全部办理完成了解除质押业 务。 ...

截至发稿，塞力医疗市值为56亿元。 每经头条（nbdtoutiao）——未收车就要结清20多万元尾款，否则5000元定金作废？小米汽车知情人 士：涉及两种特殊情况；律师解读→ （记者 王晓波） 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每经AI快讯，塞力医疗（SH 603716，收盘价：29.18元）8月12日晚间发布公告称，塞力斯医疗科技集 团股份有限公司控股股东赛海（上海）健康科技有限公司持有公司约2164万股无限售条件流通股股票， 占公司总股本的11.33%。赛海科技累计质押公司股份1400万股，占其持有公司股份比例为64.69%，占 公司总股本比例为7.33%。 公司实际控制人温伟先生持有公司股份约963万股，占公司总股本比例为5.04%。近日，温伟先生将其 中300万股股份办理完成了解除质押登记手续，本次解除质押手续办理完毕后，温伟先生累计质押公司 股份530万股，占其持有公司股份比例为55.01%，占公司总股本比例为2.77% 。截至本公告披露日，公司控股股东赛海科技及实际控制人温伟先生累计质押公司股份数为1930万股， 占其合计持有公司股份比例为61. ...

| 证券代码：603716 | 证券简称：塞力医疗 | 公告编号：2025-069 | | --- | --- | --- | | 债券代码：113601 | 债券简称：塞力转债 | | 塞力斯医疗科技集团股份有限公司 关于"塞力转债"付息公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 塞力斯医疗科技集团股份有限公司（以下简称"公司"）2020 年 8 月 21 日 公开发行的可转换公司债券（以下简称"本期债券"）将于 2025 年 8 月 21 日支 付自 2024 年 8 月 21 日至 2025 年 8 月 20 日期间的利息。根据公司《公开发行可 转换公司债券募集说明书》（以下简称"《募集说明书》"）及《公开发行可转 换公司债券上市公告书》（以下简称"《上市公告书》"）有关条款的规定，现 将有关事项公告如下： | 债券名称 | 塞力斯医疗科技集团股份有限公司可转换公司债券 | | --- | --- | | 债券简称 | 塞力转债 | | 债券代码 | 113601 | | 债券类型 | 可转换为 ...